Saltar al contenido
Merck

Saltar a

C7165

Citrate-phosphate-dextrose solution

aseptically filled

Sinónimos:

Citrate-phosphate-glucose

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas
A ustedes/SKUDisponibilidadPrecio

Acerca de este artículo

NACRES:
NA.25
UNSPSC Code:
12161700
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


sterility

aseptically filled

Quality Segment

form

liquid

pH

5.2-5.8

storage temp.

2-8°C

General description

Citrate-phosphate-dextrose solution (CPD) is an anticoagulant solution. It has 15% less citrate ion over citrate-phosphate-dextrose solution with adenine (ACD) and provides improved isotonicity, oxygen release function and posttransfusion viability for red blood cells.

Application

Citrate-phosphate-dextrose solution has been used as an anti-coagulant in bovine blood. It has also been used in the storage of fluorescein isothiocyanate (FITC) labeled erythrocytes. Citrate-phosphate-dextrose solution is suitable for erythrocyte survival studies and whole blood storage.

Other Notes

Suggested anticoagulant: whole blood ratio: 1:14

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo
C4431C3821A3551
Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

400

form

liquid

form

liquid

form

liquid

form

liquid

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

2-8°C

storage temp.

room temp

pH

5.2-5.8

pH

5.4-6.7

pH

4.5-5.5

pH

-

sterility

aseptically filled

sterility

sterile-filtered

sterility

sterile-filtered

sterility

sterile-filtered


Clase de almacenamiento

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



Preguntas

1–4 de 4 Preguntas  
  1. C7165-50M is suitable for use in humans? I need ACD-A for PRP preparation

    1 respuesta
    1. Unless otherwise stated, this product is intended for research use only. It is not suitable for any other purpose, which includes, but is not limited to, unauthorized commercial use, in vitro diagnostic use, or therapeutic use in humans or animals. A Citrate-phosphate-dextrose solution suitable for human use is not currently offered.

      ¿Le ha resultado útil?

  2. Provide the ingredients if available for CPD Catalog #C7165?

    1 respuesta
    1. The solution contains 0.30% citric acid anhydrous, 2.63% trisodium citrate dihydrate, 0.193% sodium phosphate monobasic anhydrous, and 2.32% glucose anhydrous, all w/v.

      ¿Le ha resultado útil?

  3. What is the Department of Transportation shipping information for this product?

    1 respuesta
    1. Transportation information can be found in Section 14 of the product's (M)SDS.To access the shipping information for this material, use the link on the product detail page for the product.

      ¿Le ha resultado útil?

  4. For the anticoagulant Product C7165, Citrate-Phosphate-Dextrose solution, what is the proper anticoagulant to whole blood ratio to use?

    1 respuesta
    1. Our search of the literature shows that Citrate-Phosphate-Dextrose solution is typically used at a ratio of 1:7 or 1:9, but we do indeed test it at 1:14...the thinking being that if it works at 1:14, it will surely work at 1:7 or 1:9. The description of Product C7165, Citrate-Phosphate-Dextrose solution, suggests using it at an anticoagulant to whole blood ratio of 1.4 to 10 (about 1:7), but the specification sheet shows that it is tested at an anticoagulant to whole blood ratio of 1:14.

      ¿Le ha resultado útil?

Revisiones

Sin puntuación

Filtros activos